Hemostasis in Pregnancy Induced Hypertension (PIH)
DOI:
https://doi.org/10.7439/ijbar.v8i6.4203Keywords:
Ethosomes, Transdermal drug delivery, Ethosomal encapsulation, Ethosomes effectsAbstract
Background: Pregnancy is a hypercoagulable state as the parturient is physiologically prepared against haemorrhage. Plasma fibrinogen level increases and platelet count decreases. Pregnancy induced Hypertension (PIH) is a syndrome complex of hypertension, oedema and proteinuria. In PIH, the physiological changes that occur in normal pregnancy are further aggravated and the woman is prone to develop Disseminated Intravascular Coagulation (DIC) which is a chief pathogenic factor in PIH. Objective: 1.To estimate platelet count and serum fibrinogen in normal pregnant women and women with PIH.2.To do bleeding time and clotting time in normal pregnant women and women with PIHand compare both. Material and methods: Two groups of pregnant women were involved. The first group (control) comprises normal pregnant women. The study group consists of pregnant women with PIH. Platelet count was done by direct method. Serum Fibrinogen was estimated by Rapid Turbidimetric method. Bleeding time was measured by Duke Method and Clotting time was measured by Wrights capillary tube method. Statistical analysis was done using appropriate student t test and SD. Results: In PIH group, platelet count is moderately reduced (Mean 1.72, P= 0.05) and bleeding time is prolonged (mean 117.45, P0.001), Serum fibrinogen level is reduced (mean 237.14, P 0.001) and clotting time is prolonged(mean 16.9,P 0.001). Conclusion: Pregnant women with PIH are more prone to develop coagulation abnormalities which may result in bleeding tendency. Hence, serial estimations of platelet count and bleeding time can be used to assess primary hemostatic function. Plasma fibrinogen level and clotting time measurement may be used to assess secondary hemostatic function.Downloads
Download data is not yet available.
Downloads
Published
2017-06-29
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
Hemostasis in Pregnancy Induced Hypertension (PIH). (2017). International Journal of Biomedical and Advance Research, 8(6), 250-254. https://doi.org/10.7439/ijbar.v8i6.4203